Evidence map›Paper›PMID 37471331›Full record

ArticlePloS one2023

Radioactive contamination in feral dogs in the Chernobyl exclusion zone: Population body-burden survey and implications for human radiation exposure.

Jake Hecla, Erik Kambarian, Robert Tubbs, Carla McKinley, Aaron J Berliner, Kayla Russell, Gabrielle Spatola, Jordan Chertok, Weston Braun, Natalia Hank and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 3 countries.

Jake HeclaDepartment of Nuclear Engineering, University of California Berkeley, Berkeley, California, United States of America.
Erik KambarianClean Futures Fund, Godfrey, Illinois, United States of America.
Robert TubbsTubbs Nuclear Consulting, Auburn, Washington, United States of America.
Carla McKinleyDepartment of Nuclear Engineering, University of California Berkeley, Berkeley, California, United States of America.
Aaron J BerlinerDepartment of Nuclear Engineering, University of California Berkeley, Berkeley, California, United States of America.ORCID 0000-0002-4817-3926
Kayla RussellSchool of Veterinary Medicine, University College Dublin, Dublin, Ireland.
Gabrielle SpatolaDepartment of Biological Sciences, University of South Carolina, Columbia, South California, United States of America.
Jordan ChertokCollege of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, United States of America.
Weston BraunDepartment of Electrical Engineering, Stanford University, Palo Alto, California, United States of America.
Natalia HankCollege of Veterinary Medicine, Kansas State University, Manhattan, Kansas, United States of America.
Courtney MarquetteSchool of Veterinary Medicine, University College Dublin, Dublin, Ireland.
Jennifer BetzClean Futures Fund, Godfrey, Illinois, United States of America.
Terry PaikClean Futures Fund, Godfrey, Illinois, United States of America.
Marie CheneryClean Futures Fund, Godfrey, Illinois, United States of America.
Alex CaganWellcome Sanger Institute, Hinxton, United Kingdom.
Carl WillisDepartment of Nuclear Engineering, University of New Mexico, Albuquerque, New Mexico, United States of America.
Tim MousseauDepartment of Biological Sciences, University of South Carolina, Columbia, South California, United States of America.
Futures Group (United States) · USUniversity College Dublin · IEUniversity of California, Berkeley · USUniversity of South Carolina · USKansas State University · USKnoxville College · USStanford University · USUniversity of New Mexico · USWellcome Sanger Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes a two-year effort to survey the internal 137Cs and external β-emitter contamination present in the feral dog population near the Chernobyl nuclear power plant (ChNPP) site, and to understand the potential for human radiation exposure from this contamination. This work was performed as an integral part of the radiation safety and control procedures of an animal welfare oriented trap-neuter-release (TNR) program. The measurement program focused on external contamination surveys using handheld β-sensitive probes, and internal contamination studies using a simple whole-body counter. Internal 137Cs burden was measured non-invasively during post-surgical observation and recovery. External β contamination surveys performed during intake showed that 21/288 animals had significant, removable external contamination, though not enough to pose a large hazard for incidental contact. Measurements with the whole-body counter indicated internal 137Cs body burdens ranging from undetectable (minimum detection level ∼100 Bq/kg in 2017, ∼30 Bq/kg in 2018) to approximately 30,000 Bq/kg. A total of 33 animals had 137Cs body-burdens above 1 kBq/kg, though none posed an external exposure hazard. The large variation in the 137Cs concentration in these animals is not well-understood, could be due to prey selection, access to human food scraps, or extended residence in highly contaminated areas. The small minority of animals with external contamination may pose a contamination risk allowing exposures in excess of regulatory standards.

Indexed as

Chernobyl Nuclear AccidentFood Contamination, RadioactiveRadiation ExposureRadiation MonitoringRadioactive Hazard ReleaseAnimalsBody BurdenCesium RadioisotopesDogsHumansNuclear Power PlantsUkraineCesium-137Cesium Radioisotopes

Identifiers

PMID37471331
PMCPMC10358910
OpenAlexW4384926339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.